merged_alzheimers-blood-test.txt
<question_number>1</question_number>
<answer>No available therapies and risk of psychological reactions.</answer>
<question_number>2</question_number>
<answer>About 90% versus roughly 59% accuracy.</answer>
<question_number>3</question_number>
<answer>Because many individuals with subjective cognitive decline do not actually have Alzheimerâ€™s pathology.</answer>
<question_number>4</question_number>
<answer>Integration of blood test analysis into hospital laboratory systems.</answer>
<question_number>5</question_number>
<answer>ptau-217 (a form of tau protein).</answer>
<question_number>6</question_number>
<answer>Only in individuals with symptoms or within research studies.</answer>
<question_number>7</question_number>
<answer>Kidney disease.</answer>
<question_number>8</question_number>
<answer>It may cause anxiety and other psychological reactions without offering any treatment.</answer>
<question_number>9</question_number>
<answer>41%</answer>
<question_number>10</question_number>
<answer>It could increase access to screening.</answer>